| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akoya Biosciences, Inc. | Chief Clinical Officer | Common Stock | 0 | $0 | $1.16 | 08 Jul 2025 | Direct |
| Akoya Biosciences, Inc. | Chief Clinical Officer | Employee Stock Option (Right to Buy) | 0 | 08 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKYA | Akoya Biosciences, Inc. | 08 Jul 2025 | 6 | $0 | 4 | Chief Clinical Officer | 10 Jul 2025, 20:39 |
| AKYA | Akoya Biosciences, Inc. | 01 Jun 2025 | 1 | -$838 | 4 | Chief Clinical Officer | 02 Jun 2025, 17:52 |
| AKYA | Akoya Biosciences, Inc. | 01 Mar 2025 | 2 | -$6,276 | 4 | Chief Clinical Officer | 04 Mar 2025, 17:09 |
| AKYA | Akoya Biosciences, Inc. | 19 Nov 2024 | 1 | $0 | 4 | Chief Clinical Officer | 21 Nov 2024, 17:20 |
| AKYA | Akoya Biosciences, Inc. | 29 Aug 2024 | 1 | $0 | 4 | Chief Clinical Officer | 03 Sep 2024, 21:41 |
| AKYA | Akoya Biosciences, Inc. | 29 Aug 2024 | 0 | $0 | 3 | Chief Clinical Officer | 03 Sep 2024, 21:40 |